Divi's Laboratories Limited · NSE:DIVISLAB

Divi's Laboratories Limited financial statements

Divi's Laboratories Limited's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in INR

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue105.6B93.3B78.0B76.7B88.0B68.6B52.9B48.0B38.1B40.5B
Cost of revenue60.0B38.7B32.7B31.8B30.9B24.3B5.59B1.96B4.79B2.38B
Gross profit45.6B54.5B45.3B44.9B57.1B44.3B47.3B46.1B33.3B38.2B
Research and development400.0M270.0M350.0M300.0M202.9M149.7M111.4M106.0M101.1M119.5M
Selling, general and administrative3.16B1.43B1.25B1.26B1.09B831.4M746.9M542.3M905.3M428.1M
Operating income29.8B25.7B18.3B20.3B35.7B26.2B16.4B17.1B11.3B13.6B
Depreciation and amortization4.63B4.02B3.78B3.43B3.12B2.56B1.86B1.69B1.42B1.23B
EBITDA34.4B29.7B22.1B23.7B38.9B28.7B18.3B18.8B12.7B14.9B
Interest expense230.0M30.0M30.0M19.6M19.9M20.9M71.3M28.5M23.5M21.7M
Income before tax33.9B29.2B21.6B23.7B36.8B26.7B18.2B18.6B12.3B14.0B
Income tax8.20B7.25B5.63B5.45B7.23B6.82B4.43B5.02B3.54B3.35B
Net income25.7B21.9B16.0B18.2B29.6B19.8B13.8B13.5B8.77B10.6B
Earnings per share, basic96.7582.5360.2768.71111.5274.7551.8550.9633.0439.95

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents1.28B4.32B3.63B1.70B12.1B20.3B431.5M130.0M251.5M207.9M
Short-term investments31.1B31.2B33.4B39.7B15.3B546.4M110.1M14.0B18.9B16.3B
Receivables31.1B29.8B21.6B17.9B24.3B16.2B14.5B585.4M433.8M9.39B
Inventory39.5B33.2B31.8B30.0B28.3B21.5B18.6B17.7B13.5B13.6B
Current assets111.0B100.8B96.8B93.1B83.5B61.7B46.8B46.5B45.4B40.1B
Property, plant and equipment64.6B55.1B49.3B47.9B44.1B37.0B25.8B21.1B20.0B
Total assets200.3B169.5B154.7B144.4B133.7B107.7B85.4B80.4B67.9B61.6B
Accounts payable12.1B9.10B8.24B7.62B7.96B7.63B5.91B4.92B4.11B4.46B
Current liabilities20.4B14.5B12.8B11.0B12.0B11.1B9.27B8.47B6.53B6.59B
Total debt70.0M40.0M30.0M44.9M36.9M48.3M388.5M1.06B631.1M357.4M
Total liabilities32.7B19.8B19.0B16.7B16.5B14.8B12.3B10.8B8.61B8.01B
Shareholders' equity167.6B149.7B135.7B127.7B117.3B92.9B73.1B69.6B59.2B53.6B
Shares outstanding265.4M265.5M265.5M265.5M265.5M265.5M265.5M265.5M265.5M265.5M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations30.2B19.5B12.6B24.6B19.1B19.5B12.2B9.54B7.76B11.5B
Capital spending-25.2B-14.4B-10.0B-4.73B-7.13B-9.10B-11.8B-7.33B-2.74B-3.77B
Free cash flow4.97B5.08B2.58B19.9B12.0B10.4B327.3M2.21B5.02B7.74B
Cash from investing-25.0B-11.0B-2.69B-27.1B-21.9B751.3M-834.7M-6.85B-4.78B-11.4B
Cash from financing-7.99B-7.97B-7.99B-7.97B-5.32B-348.9M-10.9B-2.46B-3.14B23.8M
Dividends paid-7.97B-7.96B-7.96B-7.96B-5.31B-5.31B-10.2B-3.20B-3.19B-3.19B
Change in cash29.8B610.0M1.93B-10.5B-8.16B19.9B410.5M229.6M-166.0M-222.1M